Jove
Visualize
Contact Us

Related Experiment Videos

Will we need lymph node dissection at all in the future?

Robert L J H Bourez1, Emiel J Th Rutgers, Cornelius J H Van De Velde

  • 1Department of Radiology, Medical Center Haaglanden, The Hague, The Netherlands.

Clinical Breast Cancer
|January 21, 2003
PubMed
Summary

Axillary lymph node dissection (ALND) is often unnecessary for breast cancer patients. Sentinel node procedures and radiotherapy offer alternatives for staging and control, reducing morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.

Breast cancer research and treatment·2023
Same author

Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.

The American journal of surgical pathology·2019
Same author

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node.

Journal for immunotherapy of cancer·2019
Same author

[A woman with a painful swelling in the breast].

Nederlands tijdschrift voor geneeskunde·2019
Same author

Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancer.

Nuclear medicine communications·2019
Same author

Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.

Journal of surgical oncology·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiotherapy

Background:

  • Axillary lymph node dissection (ALND) is a traditional procedure for primary breast cancer treatment.
  • A significant number of patients undergo ALND without nodal involvement, leading to unnecessary treatment.
  • Reasons for ALND include staging, determining treatment extent, and axillary tumor control.

Purpose of the Study:

  • To evaluate the necessity and efficacy of ALND in primary breast cancer treatment.
  • To compare ALND with alternative methods like sentinel node biopsy and radiotherapy.
  • To determine the future role of ALND in breast cancer management.

Main Methods:

  • Literature review of studies on axillary nodal staging, adjuvant treatment, and regional control.

Related Experiment Videos

  • Comparison of outcomes between ALND, sentinel node procedures, and radiotherapy.
  • Analysis of evidence regarding the benefits of extensive nodal involvement treatment.

    • Main Results:

    • Sentinel node procedures are equivalent to ALND for staging in node-negative patients.
    • No clear evidence shows benefit from intensified adjuvant treatment for extensive nodal involvement (>= 4 positive nodes).
    • Radiotherapy provides similar axillary control to ALND in node-negative cases; ALND may improve regional control in overt involvement.

    Conclusions:

    • ALND is increasingly unnecessary and should be reserved for patients with confirmed lymph node involvement.
    • Sentinel node biopsy and radiotherapy are viable alternatives with potentially less morbidity.
    • Future breast cancer treatment paradigms will likely de-emphasize routine ALND.